Oral Presentations 09- Miscellanous

16:00 • 699 • Are Large Language Models Ready for Therapeutic Drug Monitoring? A Multi-Dimensional Performance Evaluation Across Real-World Clinical Scenarios > Z. Zaiwei Song 16:13 • 538 • Exploring therapeutic drug monitoring of CFTR modulator therapy in cystic fibrosis > N. Nick Verougstraete 16:26 • 502 • From Cardiovascular Therapy to Rare Disease Care: PBPK Modeling of Losartan Enabling Application in Epidermolysis Bullosa > V. Veronika Alberg 16:39 • 423 • Beyond “Skip or Take”: Evidence-Based Missed-Dose Guidance Using PopPK Simulations > R. Racym BERRAH 16:52 • 202 • From Population Pharmacokinetics to Machine Learning: Toward Precision Dosing of Hydroxyurea in Pediatric Sickle Cell Disease > C. Claire PRESSIAT 17:05 • 231 • Mavacamten therapeutic drug monitoring by HPLC-MS/MS for the real-life follow-up of patients with obstructive hypertrophic cardiomyopathy: what’s the use ? > J-Y. Jean-Yves Jouzeau 17:18 • 5 • Pharmacometabolomics reveals notable differences between real-world and expected drug metabolism and excretion patterns > F. Frank KLONT